VCBeat has learned that, recently,Beijing Jingmiao Health Technology Co., Ltd., a medical big data company (hereinafter referred to as “Jingmiao Health”)Announces Receipt ofZhisheng LongguanofTens of Millions in Angel RoundFinancing. It is reported that this round of financing will be mainly used to expand R&D investment and accelerate the application of artificial intelligence technology in hospital scenarios.
Jingmiao Health was founded in 2019, with its headquarters in Beijing,Jingmiao Health is a health technology company based on knowledge graphs and artificial intelligence algorithms.. The company’s founders have nearly 20 years of experience in the healthcare industry, with extensive expertise in medical sector operations and product development, as well as strong capabilities in corporate management and marketing. Its primary products include Western medicine and Traditional Chinese Medicine (TCM) knowledge bases, medical knowledge graphs, medical record data governance systems, electronic medical record (EMR) quality control systems, and medical Q&A chatbots.
The smart healthcare industry boasts broad market prospects. According to the latest "White Paper on the Medical Intelligence Industry" released by Frost & Sullivan ("Sullivan"), as China’s public health and medical information systems continue to improve, the Chinese medical industry is transitioning from Healthcare Informatics 1.0 to Healthcare Intelligence 3.0. The market size of China’s medical intelligence industry is projected to exceed RMB 1.1 trillion by 2030. In 2021, the scale of smart hospital applications in China will reach RMB 75.4 billion. The market size is expected to reach RMB 173.7 billion by 2027, with a compound annual growth rate (CAGR) of 15.51%.
Jingmiao Health is dedicated to medical knowledge and healthcare big data, enabling the practical application of both for users. By continuously investing in key technologies, product development, and service implementation, we deliver faster, more comprehensive, more accurate, and smarter medical knowledge, data products, and services, thereby creating sustained value for our users.
Jingmiao Health’s implemented client cases includeCapital Institute of Pediatrics, Shandong Provincial Hospital, Yantai Affiliated Hospital of Binzhou Medical University, Guangdong Provincial Hospital of Traditional Chinese Medicine, The First People's Hospital of Foshan, Guangdong, The Affiliated Hospital of Henan University of Science and Technology, Hubei Provincial Health Commissionetc.
Investors in This RoundZhisheng Longguan FundA professional private equity investment fund, filed with the Asset Management Association of China (AMAC) and initiated by alumni of Peking University, Tsinghua University, and the University of Chinese Academy of Sciences, focusing on investing in and incubating early-stage hard-tech startups that possess core competitiveness and can create significant social value.
Mr. Hu Yangbing, Executive Partner of Zhisheng Longguan Fundstated: “The founding team members of Jingmiao Health possess over two decades of experience in the healthcare industry. Having worked together for many years, they have clear divisions of labor, complementary strengths, and seamless collaboration. By continuously refining its medical knowledge graph and artificial intelligence algorithms, Jingmiao Health consistently helps hospitals improve the quality of care. We are highly optimistic about the Jingmiao Health team and affirm the entrepreneurial vision of its founders, Mr. Chen Zhongwei and Mr. Yuan Qinzhi. We hope that, under their leadership, Jingmiao Health will make significant contributions to China’s smart healthcare initiative.””